Skip to content

Michigan Men's Diabetes Project

Michigan Men's Diabetes Project (MenD) - Peer Leader Intervention

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04760444
Enrollment
25
Registered
2021-02-18
Start date
2021-05-15
Completion date
2022-01-31
Last updated
2023-06-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Diabetes Mellitus, Type 2

Brief summary

The investigators propose to develop a training for male peer leaders facilitating diabetes self-management education and support (DSMES) to specifically encourage conversations regarding beliefs that affect men's health and to allow modeling of alternative views and perspectives that allow for successful disease management to be framed as competence and strength. Given that the life expectancy for Black men in the US is 71, the investigators hypothesize that targeting men in earlier stages of type 2 diabetes (T2D) will assist greatly in facilitating healthy aging and improving diabetes-related health outcomes later in life. Based on the investigators previous work, the long-term goal of our research is to determine the most effective, practical, and sustainable approach to provide DSMES to older Black men. The objective is to examine the relative effectiveness, feasibility, and acceptability of a peer-leader DSMES intervention for Black men with T2D. To accomplish this, the investigators will engage in a developmental phase and a validation phase \[pilot randomized control trial (RCT)\]. The RCT will be conducted with 60 Black adult male residents of metro Detroit, Michigan. Participants will be randomized to a control group or the tailored peer-leader diabetes self-management support group (PLDSMS). All participants will receive DSME with a certified diabetes care and education specialists. Only participants randomized to the PLDSMS group will also receive an additional 6 weeks of DSMS led by the peer leaders. The investigators hypothesize that 1) participants in the PLDSMS group will have improved outcomes (A1c, blood pressure, weight, diabetes distress, self-management behaviors, etc.) over the control group, and 2) an evaluation of measures will confirm efficacy of the PLDSMS.

Interventions

BEHAVIORALPeer Leader Diabetes Self-Management Support

While the effectiveness of peer-led interventions delivering diabetes-related education and support for short-term clinical, psychosocial, and behavioral improvements is well-established, older Black men in particular are less likely to participate and are at a higher risk of drop-out from these studies. This intervention aims to determine if using older Black men as peer leaders to other older Black men will improve retention rates for this population.

BEHAVIORALVirtual Diabetes Self-Management Education

Participants will attend 10 hours of virtual group diabetes self-management education classes led by a certified diabetes care and education specialist through the online HIPPA compliant Zoom, Med platform.

Sponsors

Blue Cross Blue Shield of Michigan Foundation
CollaboratorOTHER
National Institutes of Health (NIH)
CollaboratorNIH
National Institute on Aging (NIA)
CollaboratorNIH
University of Michigan
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
HEALTH_SERVICES_RESEARCH
Masking
NONE

Eligibility

Sex/Gender
MALE
Age
55 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Male * Age 55 or older * Black/African American * Diagnosis of type 2 diabetes for a six-month duration or longer.

Exclusion criteria

* Non-ambulatory * Serious health conditions (morbid obesity and severe symptomatic heart disease, visual impairment, renal failure, and peripheral neuropathy) * Psychiatric illness (severity requiring hospitalization) * Cognitive deficit * Serious diabetes complications (e.g. blindness) that would impede meaningful participation.

Design outcomes

Primary

MeasureTime frameDescription
Hemoglobin A1C3 monthsThis outcome measure is change in hemoglobin A1C measured using the DCA 2000 point-of-care testing instrument (value at 3 months minus value at baseline).
Self-Care Activities3 monthsThis outcome measure is change in self-care activities as measured by the Summary of Diabetes Self-Care Activities (SDSCA) scale (value at 3 months minus value at baseline). The SDSCA measure is a brief self-report questionnaire of diabetes self-management that includes items assessing the following aspects of the diabetes regimen: general diet, specific diet, exercise, blood-glucose testing, foot care, and smoking. The range for the general diet, specific diet, exercise, blood-glucose testing, and foot care sub scales included below is 0 to 7. Higher scores are indicative of more frequent self-care activities compared to lower scores.

Secondary

MeasureTime frameDescription
Depressive Symptom Severity3 monthsThis outcome measure is change in depressive symptom severity as measured by the Patient Health Questionnaire-2 (PHQ-2) Scale (value at 3 months minus value at baseline). Scores range from 0 to 6. Higher scores are indicative of more depressive symptoms.
Body Mass Index (BMI)3 monthsThis outcome measure is change in BMI (value at 3 months minus value at baseline). BMI was calculated using height and weight. Height was measured using a stadiometer. Weight was measured on a high quality, calibrated digital scale. The BMI categories are: Underweight = \<18.5; Normal weight = 18.5-24.9; Overweight = 25-29.9; Obesity = BMI of 30 or greater.
Diabetes Distress3 monthsThis outcome measure is change in diabetes distress as measured by the 17-item Diabetes Distress Scale (DDS17) (value at 3 months minus value at baseline). Scores for the DDS17 range from 1 to 6. Higher scores are indicate higher diabetes distress. A score of 2 - 2.9 is considered 'moderate distress,' and a score greater than 3.0 is considered 'high distress.'
Diabetes Self-Efficacy3 monthsThis outcome measure is change in diabetes self-efficacy as measured by the 8-item Diabetes Self-Efficacy Scale (DSES) (value at 3 months minus value at baseline). The scores for this scale range from 1 to 10. Higher scores are indicative of higher self-efficacy.
Blood Pressure3 monthsThe outcome measure is the change in blood pressure (value at 3 months minus value at baseline). Blood pressure was measured using the auscultatory method.

Countries

United States

Participant flow

Participants by arm

ArmCount
Peer Leader Diabetes Self-Management Support (PLDSMS)
Participants in the PLDSMS arm will receive 10 hours of group diabetes self-management education (DSME) with a certified diabetes care and education specialist. After the DSME group sessions, the group will complete 6 1-hour weekly diabetes self-management support (DSMS) session led by two peer leaders. Peer Leader Diabetes Self-Management Support: While the effectiveness of peer-led interventions delivering diabetes-related education and support for short-term clinical, psychosocial, and behavioral improvements is well-established, older Black men in particular are less likely to participate and are at a higher risk of drop-out from these studies. This intervention aims to determine if using older Black men as peer leaders to other older Black men will improve retention rates for this population. Virtual Diabetes Self-Management Education: Participants will attend 10 hours of virtual group diabetes self-management education classes led by a certified diabetes care and education specialist through the online HIPPA compliant Zoom, Med platform.
12
Control Group
Participants in the control group will receive 10 hours of group diabetes self-management education (DSME) with a certified diabetes care and education specialist. Virtual Diabetes Self-Management Education: Participants will attend 10 hours of virtual group diabetes self-management education classes led by a certified diabetes care and education specialist through the online HIPPA compliant Zoom, Med platform.
13
Total25

Baseline characteristics

CharacteristicPeer Leader Diabetes Self-Management Support (PLDSMS)Control GroupTotal
Age, Categorical
<=18 years
0 Participants0 Participants0 Participants
Age, Categorical
>=65 years
6 Participants4 Participants10 Participants
Age, Categorical
Between 18 and 65 years
6 Participants9 Participants15 Participants
Age, Continuous62.1 years
STANDARD_DEVIATION 5.8
64.4 years
STANDARD_DEVIATION 5.6
62.8 years
STANDARD_DEVIATION 7.1
Hemoglobin A1C7.7 percent Hemoglobin A1C
STANDARD_DEVIATION 2.2
7.4 percent Hemoglobin A1C
STANDARD_DEVIATION 1.3
7.5 percent Hemoglobin A1C
STANDARD_DEVIATION 1.7
Race (NIH/OMB)
American Indian or Alaska Native
0 Participants0 Participants0 Participants
Race (NIH/OMB)
Asian
0 Participants0 Participants0 Participants
Race (NIH/OMB)
Black or African American
12 Participants13 Participants25 Participants
Race (NIH/OMB)
More than one race
0 Participants0 Participants0 Participants
Race (NIH/OMB)
Native Hawaiian or Other Pacific Islander
0 Participants0 Participants0 Participants
Race (NIH/OMB)
Unknown or Not Reported
0 Participants0 Participants0 Participants
Race (NIH/OMB)
White
0 Participants0 Participants0 Participants
Region of Enrollment
United States
12 participants13 participants25 participants
Sex: Female, Male
Female
0 Participants0 Participants0 Participants
Sex: Female, Male
Male
12 Participants13 Participants25 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
deaths
Total, all-cause mortality
0 / 120 / 13
other
Total, other adverse events
0 / 120 / 13
serious
Total, serious adverse events
0 / 120 / 13

Outcome results

Primary

Hemoglobin A1C

This outcome measure is change in hemoglobin A1C measured using the DCA 2000 point-of-care testing instrument (value at 3 months minus value at baseline).

Time frame: 3 months

ArmMeasureValue (MEAN)Dispersion
Peer Leader Diabetes Self-Management Support (PLDSMS)Hemoglobin A1C-0.20 percent of hemoglobin A1cStandard Error 0.3
Control GroupHemoglobin A1C-0.13 percent of hemoglobin A1cStandard Error 0.31
Primary

Self-Care Activities

This outcome measure is change in self-care activities as measured by the Summary of Diabetes Self-Care Activities (SDSCA) scale (value at 3 months minus value at baseline). The SDSCA measure is a brief self-report questionnaire of diabetes self-management that includes items assessing the following aspects of the diabetes regimen: general diet, specific diet, exercise, blood-glucose testing, foot care, and smoking. The range for the general diet, specific diet, exercise, blood-glucose testing, and foot care sub scales included below is 0 to 7. Higher scores are indicative of more frequent self-care activities compared to lower scores.

Time frame: 3 months

ArmMeasureGroupValue (MEAN)Dispersion
Peer Leader Diabetes Self-Management Support (PLDSMS)Self-Care ActivitiesGeneral Diet1.32 units on a scaleStandard Error 0.51
Peer Leader Diabetes Self-Management Support (PLDSMS)Self-Care ActivitiesExercise0.95 units on a scaleStandard Error 0.56
Peer Leader Diabetes Self-Management Support (PLDSMS)Self-Care ActivitiesBlood-Glucose Testing0.50 units on a scaleStandard Error 0.22
Peer Leader Diabetes Self-Management Support (PLDSMS)Self-Care ActivitiesFoot Care0.41 units on a scaleStandard Error 0.53
Peer Leader Diabetes Self-Management Support (PLDSMS)Self-Care ActivitiesSpecific Diet0.27 units on a scaleStandard Error 0.61
Control GroupSelf-Care ActivitiesFoot Care0.04 units on a scaleStandard Error 0.96
Control GroupSelf-Care ActivitiesGeneral Diet1.77 units on a scaleStandard Error 0.98
Control GroupSelf-Care ActivitiesSpecific Diet0.74 units on a scaleStandard Error 0.49
Control GroupSelf-Care ActivitiesBlood-Glucose Testing2.44 units on a scaleStandard Error 1.89
Control GroupSelf-Care ActivitiesExercise2.02 units on a scaleStandard Error 1.44
Secondary

Blood Pressure

The outcome measure is the change in blood pressure (value at 3 months minus value at baseline). Blood pressure was measured using the auscultatory method.

Time frame: 3 months

ArmMeasureGroupValue (MEAN)Dispersion
Peer Leader Diabetes Self-Management Support (PLDSMS)Blood PressureSystolic-5.23 mmHgStandard Error 2.58
Peer Leader Diabetes Self-Management Support (PLDSMS)Blood PressureDiastolic-1.33 mmHgStandard Error 2.52
Control GroupBlood PressureSystolic10.34 mmHgStandard Error 8.17
Control GroupBlood PressureDiastolic0.15 mmHgStandard Error 7.3
Secondary

Body Mass Index (BMI)

This outcome measure is change in BMI (value at 3 months minus value at baseline). BMI was calculated using height and weight. Height was measured using a stadiometer. Weight was measured on a high quality, calibrated digital scale. The BMI categories are: Underweight = \<18.5; Normal weight = 18.5-24.9; Overweight = 25-29.9; Obesity = BMI of 30 or greater.

Time frame: 3 months

ArmMeasureValue (MEAN)Dispersion
Peer Leader Diabetes Self-Management Support (PLDSMS)Body Mass Index (BMI)-0.31 kg/m^2Standard Error 0.29
Control GroupBody Mass Index (BMI)-0.41 kg/m^2Standard Error 0.5
Secondary

Depressive Symptom Severity

This outcome measure is change in depressive symptom severity as measured by the Patient Health Questionnaire-2 (PHQ-2) Scale (value at 3 months minus value at baseline). Scores range from 0 to 6. Higher scores are indicative of more depressive symptoms.

Time frame: 3 months

ArmMeasureValue (MEAN)Dispersion
Peer Leader Diabetes Self-Management Support (PLDSMS)Depressive Symptom Severity-0.45 units on a scaleStandard Error 0.55
Control GroupDepressive Symptom Severity0.09 units on a scaleStandard Error 0.52
Secondary

Diabetes Distress

This outcome measure is change in diabetes distress as measured by the 17-item Diabetes Distress Scale (DDS17) (value at 3 months minus value at baseline). Scores for the DDS17 range from 1 to 6. Higher scores are indicate higher diabetes distress. A score of 2 - 2.9 is considered 'moderate distress,' and a score greater than 3.0 is considered 'high distress.'

Time frame: 3 months

ArmMeasureValue (MEAN)Dispersion
Peer Leader Diabetes Self-Management Support (PLDSMS)Diabetes Distress-3.91 units on a scaleStandard Error 2.55
Control GroupDiabetes Distress-0.68 units on a scaleStandard Error 3.28
Secondary

Diabetes Self-Efficacy

This outcome measure is change in diabetes self-efficacy as measured by the 8-item Diabetes Self-Efficacy Scale (DSES) (value at 3 months minus value at baseline). The scores for this scale range from 1 to 10. Higher scores are indicative of higher self-efficacy.

Time frame: 3 months

ArmMeasureValue (MEAN)Dispersion
Peer Leader Diabetes Self-Management Support (PLDSMS)Diabetes Self-Efficacy0.27 units on a scaleStandard Error 0.48
Control GroupDiabetes Self-Efficacy0.33 units on a scaleStandard Error 0.78

Source: ClinicalTrials.gov · Data processed: Feb 23, 2026